Henry Schein Acquires Acentus to Enhance Homecare Solutions and CGM Offerings

Henry Schein Expands Homecare Solutions with Acentus Acquisition

Henry Schein, Inc., a leading global provider of health care solutions, makes a significant stride in the home medical supply market by acquiring substantially all assets of Acentus, a national supplier specializing in Continuous Glucose Monitors (CGMs). This acquisition, announced on November 20, 2024, aligns with Henry Schein's strategy to enhance its homecare solutions platform and provide better service delivery directly to patients. With Acentus generating approximately $35 million in annual revenue, the deal is expected to be neutral to Henry Schein's non-GAAP earnings per share in 2025 and become accretive thereafter.

Stanley M. Bergman, Chairman and CEO of Henry Schein, underscores the strategic importance of this acquisition, which allows the company to effectively reach a wider range of healthcare providers, including clinics, physician practices, and health systems. By integrating Acentus's offerings, Henry Schein strengthens its capabilities in delivering CGM products directly to patients' homes, addressing the evolving needs of the healthcare landscape. This move not only expands the company's product portfolio but also solidifies its leadership position in the homecare medical supply sector.

This acquisition is part of a broader trend of growth for Henry Schein in the homecare space, following previous acquisitions such as Prism Medical Products in 2021 and Shield Healthcare and Mini Pharmacy in 2023. With the addition of Acentus, Henry Schein's annual revenue in the homecare medical products segment surpasses $350 million. The founders of Acentus—Brett Carroll, Todd Cianfrocca, Greg Duvall, and Julio Valdivia—are set to join the Henry Schein team, bringing their extensive expertise in healthcare to enhance the company’s operational success and clinical outcomes.

In a rapidly changing healthcare environment, Henry Schein continues to focus on improving the delivery of medical supplies and services. The company currently serves over 1 million customers worldwide, with a diverse product offering that includes more than 300,000 branded and private-label items. As a FORTUNE 500 company with reported sales of $12.3 billion in 2023, Henry Schein remains committed to advancing healthcare solutions that foster efficiency and quality in patient care.

Through strategic acquisitions like Acentus, Henry Schein not only strengthens its market position but also reinforces its dedication to meeting the needs of healthcare providers and patients alike. The company's proactive approach reflects an ongoing commitment to innovation and excellence in healthcare delivery.